Our magazine is free!

for living with diabetes

Sight-saving diabetes drug gets NICE approval

Patients with diabetic macular edema were dealt a blow in Nov 2011 when health watchdog NICE refused to make Lucentis available on the NHS on the grounds is was too expensive. However, the drug, which costs about £750 per injection has been approved for specific cases. NICE said fresh analysis showed it had a superior relative effect in some patients.



Published in Diabetes medication
Sign up to our Magazine »

Leave a Comment

Submit Comment »

No Comments Yet!


nl-imageDirect to your inbox, our

free online magazine.

Sign up for the Desang Diabetes Magazine for new products, special offers and news.

*We will never email you more often than once a week (usually once a month). You can easily unsubscribe at any time. It’s finger-pricking good!

Close Don't show again